About
"In every adult there lurks a child - an eternal child, something that is becoming, is never completed, and calls for unceasing care, attention, and education. That is the part of the human personality which wants to develop and become whole."
-Carl Jung
​
It is not enough to simply overcome our suffering, but rather to thrive and become the most self-realized individuals we can be. Often that entails at least some level of healing, whether physical, emotional, relational, or even spiritual, before we can find and leverage awareness of the obstacles that stand in the way of living our fullest. My approach to psychiatry is to seamlessly blend medications and therapy so that you can truly live. While medications can be very helpful at times, I don't believe in a magic pill. It is important that you share with me your values and goals so we can also collaborate to find non-pharmacological approaches to helping you thrive.
My practice encompasses the array of general adult psychiatric needs, from minor mood issues to severe, incapacitating mental illness. I especially enjoy working with patients that struggle with ADHD, depression, anxiety, trauma, bipolar disorder, schizophrenia and related psychoses, and personality disorders, although I treat a variety of other mental and behavioral health issues as well.
The medicalization of modern psychiatry has led to fragmentation of mental health care, and patients often feel alienated, as though their problems come first and their true self is secondary. I see my patients the other way around. My aim is to help you live better, regardless of the label attached to your problems. Reach out and take a step towards improving your mental health!
​
Latham Fink, MD/PhD
Board Certified Psychiatrist
Education & Training
Psychiatry Residency:
University of Texas at Austin Dell Medical School Psychiatry Residency (2016-2020)
​
Degrees:
University of Texas Medical Branch, Galveston, TX
- Doctor of Medicine (06/2016)
- Doctor of Philosophy, Neuroscience (06/2016)
Rhodes College, Memphis, TN
Cum Laude
- Bachelor of Science, Mathematics (05/2003)
- Bachelor of Arts, Philosophy (05/2003)
Research & Publications
Articles in peer-reviewed journals:
NC Anastasio, SJ Stutz, LHL Fink, SE Swinford-Jackson, RM Sears, RJ DiLeone, KC
Rice, FG Moeller, KA Cunningham. Serotonin (5-HT) 5-HT2A Receptor (5-HT2AR):5-HT2CR Imbalance in Medial Prefrontal Cortex Associates with Motor Impulsivity. ACS Chemical Neuroscience. 2015 Jul 15;6(7):1248-58. PubMed PMID: 26120876.
​
Hamilton KR, Littlefield AK, Anastasio NC, Cunningham KA, Fink LH, Wing VC,
Mathias CW, Lane SD, Schütz CG, Swann AC, et al. Rapid-response impulsivity: Definitions, measurement issues, and clinical implications. Personal Disord. 2015 Apr;6(2):168-81. doi: 10.1037/per0000100. PubMed PMID: 25867840.
Fink LH, Anastasio NC, Fox RG, Rice KC, Moeller FG, Cunningham KA. Individual
Differences in Impulsive Action Reflect Variation in the Cortical Serotonin 5-HT2A
Receptor System. Neuropsychopharmacology. 2015 Mar 18. doi: 10.1038/npp.2015.46. [Epub ahead of print] PubMed PMID: 25666313.
Martin CB, Martin VS, Trigo JM, Chevarin C, Maldonado R, Fink LH, Cunningham
KA, Hamon M, Lanfumey L, Mongeau R. 5-HT2C receptor desensitization moderates
anxiety in 5-HTT deficient mice: from behavioral to cellular evidence. Int J
Neuropsychopharmacol. 2014 Oct 31;18(3). pii: pyu056. doi: 10.1093/ijnp/pyu056.
NC Anastasio, SJ Stutz, RG Fox, RM Sears, RB Emeson, RJ DiLeone, RT O’Neil, LH
Fink, D Li, TA Green, FG Moeller, and KA Cunningham. Functional status of the
serotonin2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate
relapse-like behaviors in cocaine dependence. Neuropsychopharmacology. 2014
Jan;39(2):370-82.
GJ Seo, LHL Fink, BA O'Hara, WJ Atwood, CS Sullivan. Evolutionarily conserved
function of a viral microRNA. J Virol. 2008 Oct; 82(20):9823-8.
​
Conference Presentations:
LHL Fink, EJ Garcia, DJ Sholler, NC Anastasio, FJ Moeller, KA Cunningham.
Individual Differences in Impulsive Action and Temporal Estimation: Interaction with
the Serotonin (5-HT) 5-HT2AR. International Society for Research on Psychedelics.
New Oreleans, LA. Oct 18-22, 2019.
LHL Fink, M Fracassi, DW Barratt, F Gonzalez-Lima. Investigating the Use of
Transcranial Infrared Laser Stimulation to Modulate Impulsivity. International Society
for Research on Impulsivity & Society for Biological Psychiatry. Chicago, IL. May
15-18, 2019.
LHL Fink, R Poondla, DW Barratt, F Gonzalez-Lima. Effect of Transcranial Infrared
Laser Stimulation to Left Prefrontal Cortex on Verbal Cognition. Society for Biological
Psychiatry. New York, NY. May 10-12, 2018.
RM Hartley, NC Anastasio, SR Gilbertson, YC Chen, RG Fox, SJ Stutz, LH Fink, SE
Swinford-Jackson, CS Watson, FG Moeller, KA Cunningham. Serotonin (5-HT)
5-HT2A receptor (5-HT2AR):5-HT2CR protein interaction as a therapeutic target:
Novel 5-HT2AR antagonist/5-HT2CR agonist heterobivalent ligands as neuroprobes.
Society for Neuroscience. Chicago, IL. October 17-21, 2015.
LHL Fink, NC Anastasio, RG Fox, FG Moeller, and KA Cunningham. A
predisposition toward inherent impulsivity is associated with elevated 5-HT2AR
expression. American Psychological Association Convention. Toronto, Ontario.
August 6-9, 2015.
KA Cunningham, NC Anastasio, SJ Stutz, LHL Fink, SE Swinford-Jackson, RM Sears, RJ DiLeone, KC Rice, FG Moeller. Serotonin (5-HT) 5-HT2A Receptor
(5-HT2AR):5-HT2CR Imbalance in Medial Prefrontal Cortex Associates with Motor
Impulsivity. Annual Meeting of the International Society for Research on Impulsivity.
Toronto, Ontario. May 13, 2015
LHL Fink, NC Anastasio, RG Fox, FG Moeller, and KA Cunningham. A
predisposition toward inherent impulsivity is associated with elevated 5-HT2AR
expression. UTMB Clinical & Translational Research Forum. Galveston, TX. February
12, 2014.
LHL Fink, NC Anastasio, RG Fox, FG Moeller, and KA Cunningham. A
predisposition toward inherent impulsivity is associated with elevated 5-HT2AR
expression. Society for Neuroscience. San Diego, CA. November 9-13, 2013.
LHL Fink, NC Anastasio, RG Fox, FG Moeller, and KA Cunningham. A
predisposition toward inherent impulsivity is associated with elevated 5-HT2AR
expression. College on Problems of Drug Dependence. San Diego, CA. June 15-23,
2013.
NC Anastasio, SJ Stutz, RG Fox, RM Sears, RB Emeson, RJ DiLeone, RT O’Neil, LH
Fink, D Li, TA Green, FG Moeller, and KA Cunningham. Maladaptive cortical
serotonin (5-HT) 5-HT2A:5-HT2C receptor balance generates aberrant impulsivity and
elevated cocaine cue reactivity. College on Problems of Drug Dependence. San Diego, CA. June 15-23, 2013.
​
LHL Fink, NC Anastasio, RG Fox, FG Moeller, and KA Cunningham. A
predisposition toward inherent impulsivity is associated with elevated 5-HT2AR
expression. Biology Behavior & Chemistry. San Antonio, TX. March 8-10, 2013.
LHL Fink, NC Anastasio, RG Fox, FG Moeller, and KA Cunningham. A
predisposition toward inherent impulsivity is associated with elevated 5-HT2AR
expression. Clinical & Translational Research Forum, Galveston, TX. February 2012.
LHL Fink, N.C. Anastasio, R.G. Fox, F. G. Moeller, and K.A. Cunningham. Elevated
5-HT2AR Expression is Associated with a Predisposition Toward Inherent Impulsivity.
International Society for Serotonin Research, Montpellier, France. July 10-12, 2012.
LHL Fink, SJ Stutz, KA Cunningham. Repeated intermittent treatment with the
selective 5-HT2CR agonist Way 163909 produces behavioral tolerance to its acute
hypomotive effects. Society for Neuroscience Galveston Chapter Poster Symposium.
Galveston, TX. October 25, 2011.
LHL Fink, SJ Stutz, KA Cunningham. Repeated intermittent treatment with the selective 5-HT2CR agonist Way 163909 produces behavioral tolerance to its acute
hypomotive effects. College on Problems of Drug Dependence. Hollywood, FL. June
18-23, 2011.
LHL Fink, SJ Stutz, MJ Bubar, KA Cunningham. Selective stimulation of the
5-HT2CR signalosome is associated with elevated basal and reduced 5-HT2CR evoked levels of novelty-induced motility. Biology Behavior & Chemistry. San Antonio, TX. March 5-6, 2011.
NC Anastasio, AG McGinnis, PK Seitz, LHL Fink, CS Watson, F Laezza, A Argakov,
A Natarajan, SR Gilbertson, KA Cunningham. Innovative strategy for maintaining
activation of the serotonin 2C receptor (5-HT2CR) signalosome. Society for Neuroscience. San Diego, CA. November 13-17, 2010.
LHL Fink, GJ Seo, BA O'Hara, D Ganem, WJ. Atwood, CS Sullivan. Biogenesis and
function of Polyomaviral microRNAs. International Conference on Polyomaviruses
and Human Diseases. Barcelona, Sep 30-Oct 3, 2007.
LHL Fink, D Ganem, CS Sullivan. Biogenesis and function of viral microRNAs. Workshop on Mechanisms of Viral Oncogenesis: DNA Repair, Genetic Instability, and
MicroRNAs. Lake Tahoe, Sep 7, 2007.
LHL Fink, D Ganem, CS Sullivan. Biogenesis and function of polyomaviral
microRNAs. ICGEB DNA Tumor Virus Meeting. Trieste, July 17-22, 2007.